Amidst the outbreak of the coronavirus pandemic, with 4,217,408 confirmed cases globally, 1,506,479 recovered with 284,736 deaths as at May 11, 2020, the whole world have been waiting for the announcement of the breakthrough in making a vaccine for the deadly virus.
However, according to CNN, a team of doctors in Hong Kong, have successfully made a breakthrough in devising a cure for the deadly virus. According to the report, the doctors have discovered two antiviral drugs and one immune system booster that have helped patients recover quickly from coronavirus infections.
The report stated that Dr. Kwok-Yung Yuen at Hong Kong University and colleagues tested HIV drug combination of Ritonavir-Lopanivir, a general antiviral drug Ribavirin and a multiple sclerosis drug Beta Interferon.
In the study published by Lancet Medical Journal, patients who had mild to moderate symptoms recovered from the deadly virus. It was also disclosed that some patients were given just HIV mixture, Ritonavir-Lopanivir by Yuen and his colleagues and they all tested negative after twelve days.
Others were randomly given the same mixture, often sold under the brand name Kaletra, plus Ribavirin and injections of Beta Interferon. Those who got the cocktail felt better within four days after one week of treatment.
“Early triple antiviral therapy was safe and superior to Lopinavir-Ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19,” the team wrote.
Dr. Peter Chin-Hong, a doctor treating COVID- 19 patients at the University of California in San Francisco, hailed the team’s discovery. He added that the team have been able to reveal that there are options available other than Remdesivir and that the track record of safety of the drugs combined and the availability of the drugs makes it an excellent discovery.
“This study is really refreshing because it tells us remdesivir isn’t the only game in town and maybe there are other options around. In COVID-19, we don’t have the luxury of time,” he noted.
“This is one of the treatment options where we are teaching old drugs, new tricks. We don’t have the time to take a drug rationally from beginning to end because we have a crisis right now. We have to make do with what we have.”
Remdesivir has been the only recognised and authorized treatment globally, having been known to shorten the duration of the disease, but it is limited in supply.